Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.

Cowell IG, Papageorgiou N, Padget K, Watters GP, Austin CA.

Nucleus. 2011 Jan-Feb;2(1):61-71. doi: 10.4161/nucl.2.1.14194.

2.

Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.

Bártová E, Pacherník J, Harnicarová A, Kovarík A, Kovaríková M, Hofmanová J, Skalníková M, Kozubek M, Kozubek S.

J Cell Sci. 2005 Nov 1;118(Pt 21):5035-46.

3.

Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.

Nielsen AL, Ortiz JA, You J, Oulad-Abdelghani M, Khechumian R, Gansmuller A, Chambon P, Losson R.

EMBO J. 1999 Nov 15;18(22):6385-95.

4.

Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.

Karagiannis TC, Harikrishnan KN, El-Osta A.

Oncogene. 2007 Jun 7;26(27):3963-71. Epub 2007 Jan 8. Erratum in: Oncogene. 2007 Jul 26;26(34):5028. Kn, H [corrected to Harikrishnan, K N].

PMID:
17213813
5.

Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα.

Chen J, Zheng Z, Chen Y, Li J, Qian S, Shi Y, Sun L, Han Y, Zhang S, Yu K.

PLoS One. 2016 Apr 8;11(4):e0153330. doi: 10.1371/journal.pone.0153330. eCollection 2016.

7.

Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A.

Felisbino MB, Gatti MS, Mello ML.

J Cell Biochem. 2014 Nov;115(11):1937-47. doi: 10.1002/jcb.24865.

PMID:
24913611
8.

Histone epigenetic marks in heterochromatin and euchromatin of the Chagas' disease vector, Triatoma infestans.

Alvarenga EM, Rodrigues VL, Moraes AS, Naves LS, Mondin M, Felisbino MB, Mello ML.

Acta Histochem. 2016 May;118(4):401-12. doi: 10.1016/j.acthis.2016.04.002. Epub 2016 Apr 11.

PMID:
27079857
9.

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.

Marchion DC, Bicaku E, Turner JG, Daud AI, Sullivan DM, Munster PN.

Clin Cancer Res. 2005 Dec 1;11(23):8467-75.

10.

Duplication and maintenance of heterochromatin domains.

Taddei A, Roche D, Sibarita JB, Turner BM, Almouzni G.

J Cell Biol. 1999 Dec 13;147(6):1153-66.

11.

A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.

Yu CC, Pan SL, Chao SW, Liu SP, Hsu JL, Yang YC, Li TK, Huang WJ, Guh JH.

Biochem Pharmacol. 2014 Aug 1;90(3):320-30. doi: 10.1016/j.bcp.2014.06.001. Epub 2014 Jun 7.

PMID:
24915421
12.

Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin.

Robbins AR, Jablonski SA, Yen TJ, Yoda K, Robey R, Bates SE, Sackett DL.

Cell Cycle. 2005 May;4(5):717-26. Epub 2005 May 28.

PMID:
15846093
13.

Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.

Taddei A, Maison C, Roche D, Almouzni G.

Nat Cell Biol. 2001 Feb;3(2):114-20.

PMID:
11175742
14.

Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.

Hajji N, Wallenborg K, Vlachos P, Füllgrabe J, Hermanson O, Joseph B.

Oncogene. 2010 Apr 15;29(15):2192-204. doi: 10.1038/onc.2009.505. Epub 2010 Feb 1.

PMID:
20118981
15.

Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.

Johnson CA, Padget K, Austin CA, Turner BM.

J Biol Chem. 2001 Feb 16;276(7):4539-42. Epub 2001 Jan 2.

16.

Cell guidance into quiescent state through chromatin remodeling induced by elastic modulus of substrate.

Rabineau M, Flick F, Mathieu E, Tu A, Senger B, Voegel JC, Lavalle P, Schaaf P, Freund JN, Haikel Y, Vautier D.

Biomaterials. 2015 Jan;37:144-55. doi: 10.1016/j.biomaterials.2014.10.023. Epub 2014 Oct 29.

PMID:
25453945
17.
18.

5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation.

Takebayashi S, Nakao M, Fujita N, Sado T, Tanaka M, Taguchi H, Okumura K.

Biochem Biophys Res Commun. 2001 Nov 9;288(4):921-6.

PMID:
11688997
19.

Efficient transcriptional silencing in Saccharomyces cerevisiae requires a heterochromatin histone acetylation pattern.

Braunstein M, Sobel RE, Allis CD, Turner BM, Broach JR.

Mol Cell Biol. 1996 Aug;16(8):4349-56.

20.

Supplemental Content

Support Center